Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines

LL Poulsen, K Taylor, DE Williams, BS Masters and DM Ziegler

Substrate activity of a flavin-containing monooxygenase isolated from rabbit lung microsomes has been examined with a number of primary, secondary, and tertiary amines. Of the secondary and tertiary amines tested, trifluoperazine, prochlorperazine, N, N-dimethyloctylamine, desmethylperazine, and N-methyloctylamine half-saturate the enzyme at concentrations less than 100 microM. Although the lung enzyme does not exhibit detectable substrate activity with primary arylamines, it catalyzes N-oxygenation of alkylamines to oximes. Studies on the mechanism for the oxidation of n-dodecylamine suggest that the amine is first oxidized to the hydroxylamine which is then further oxidized to the oxime. This interpretation is based on product identification, kinetic studies, and changes in the ratio of hydroxylamine to oxime formed as a function of initial substrate concentration. Kinetic constants calculated for the oxidation of n-dodecylamine and n- dodecylhydroxylamine indicate that the latter saturates the enzyme at a 100-fold lower concentration than that required for the parent amine, and the hydroxylamine is the dominant product only at saturating concentrations of the amine. The ratio of substrate-dependent NADPH and O2 consumption and product formation (hydroxylamine + 2 X oxime) is approximately 1.0:0.9:0.7. Although the reason for the less than stoichiometric yield of products is not known, uncoupling of the enzyme by primary amines does not appear to be a major factor since substrate- dependent increase in H2O2 formation is never more than 3% of substrate- dependent O2 consumption.

Volume 30, Issue 6, pp. 680-685, 12/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. K. Krueger, M.-F. Yueh, S. R. Martin, C. B. Pereira, and D. E. Williams Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey Drug Metab. Dispos., April 13, 2001; 29(5): 693 - 700. [Abstract] [Full Text]

				J. R. Cashman, Y. N. Xiong, L. Xu, and A. Janowsky N-Oxygenation of Amphetamine and Methamphetamine by the Human Flavin-Containing Monooxygenase (Form 3): Role in Bioactivation and Detoxication J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1251 - 1260. [Abstract] [Full Text]

				J. R. Halpert, T. L. Domanski, O. Adali, C. P. Biagini, J. Cosme, E. A. Dierks, E. F. Johnson, J. P. Jones, P. O. de Montellano, R. M. Philpot, et al. Structure-Function of Cytochromes P450 and Flavin-Containing Monooxygenases. Implications for Drug Metabolism Drug Metab. Dispos., December 1, 1998; 26(12): 1223 - 1231. [Abstract] [Full Text]

				C. T. Dolphin, D. J. Beckett, A. Janmohamed, T. E. Cullingford, R. L. Smith, E. A. Shephard, and I. R. Phillips The Flavin-containing Monooxygenase 2 Gene (FMO2) of Humans, but Not of Other Primates, Encodes a Truncated, Nonfunctional Protein J. Biol. Chem., November 13, 1998; 273(46): 30599 - 30607. [Abstract] [Full Text] [PDF]

				J. Lin and J. R. Cashman N-Oxygenation of Phenethylamine to the trans-Oxime by Adult Human Liver Flavin-Containing Monooxygenase and Retroreduction of Phenethylamine Hydroxylamine by Human Liver Microsomes J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1269 - 1279. [Abstract] [Full Text]